Currently out of the existing stock ratings of Eric Schmidt, 26 are a BUY (100%).

Eric Schmidt

Work Performance Price Targets & Ratings Chart

Analyst Eric Schmidt, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 52.68% that have a potential upside of 33.83% achieved within 1005 days.

Eric Schmidt’s has documented 52 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on AMGN, Amgen at 27-Sep-2024.

Wall Street Analyst Eric Schmidt

Analyst best performing recommendations are on BIIB (BIOGEN).
The best stock recommendation documented was for BIIB (BIOGEN) at 1/2/2018. The price target of $338 was fulfilled within 1 day with a profit of $3.83 (1.15%) receiving and performance score of 11.46.

Average potential price target upside

BIIB Biogen CELG Celgene INCY yte AMGN Amgen ALXN Alexion Pharmaceuticals BLUE Bluebird bio

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$270

$96.21 (55.36%)

$270

5 days ago
(31-Oct-2024)

7/32 (21.88%)

$96 (55.17%)

255

Buy

$204

$30.21 (17.38%)

$436

5 days ago
(31-Oct-2024)

10/12 (83.33%)

$30 (17.24%)

62

Buy

$255

$81.21 (46.73%)

$270

5 days ago
(31-Oct-2024)

24/38 (63.16%)

$81 (46.55%)

326

Buy

$300

$126.21 (72.62%)

$300

5 days ago
(31-Oct-2024)

9/19 (47.37%)

$126 (72.41%)

260

Buy

$275

$101.21 (58.24%)

$305

5 days ago
(31-Oct-2024)

11/17 (64.71%)

$101 (58.05%)

162

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Eric Schmidt is most bullish on?

Potential upside of $118.21 has been obtained for BIIB (BIOGEN)

Which stock is Eric Schmidt is most reserved on?

Potential downside of $85.78 has been obtained for AMGN (AMGEN)

What Year was the first public recommendation made by Eric Schmidt?

On 2015

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?